Stock Expert AI

SNPV ETF — Holdings & Analysis

The Xtrackers S&P 500 Value Scored & Screened ETF (SNPV) seeks to replicate the performance of the S&P 500 Value Scored & Screened Index. With an expense ratio of 0.15%, SNPV offers exposure to U.S. equities screened for value characteristics.

The fund's holdings are weighted based on a value score, differentiating it from traditional market-cap weighted ETFs. As of March 15, 2026, SNPV has approximately $0.00B in assets under management and a dividend yield of 1.95%.

Xtrackers S&P 500 Value Scored & Screened ETF (SNPV) ETF — Price, Holdings & Analysis

The Xtrackers S&P 500 Value Scored & Screened ETF (SNPV) seeks to replicate the performance of the S&P 500 Value Scored & Screened Index. With an expense ratio of 0.15%, SNPV offers exposure to U.S. equities screened for value characteristics. The fund's holdings are weighted based on a value score, differentiating it from traditional market-cap weighted ETFs. As of March 15, 2026, SNPV has approximately $0.00B in assets under management and a dividend yield of 1.95%.

ETF Overview

Xtrackers S&P 500 Value Scored & Screened ETF (the “fund”), seeks investment results that correspond generally to the performance, before fees and expenses, of the S&P 500 Value Scored & Screened Index (the “Underlying Index”).
SNPV aims to provide investors with targeted exposure to value stocks within the S&P 500. The fund tracks the S&P 500 Value Scored & Screened Index, which employs a scoring and screening process to identify companies exhibiting strong value characteristics. This approach seeks to capture potential outperformance from undervalued stocks. The ETF's top holdings include Palantir Technologies Inc Ordinary Shares - Class A (3.03%), AbbVie Inc (2.98%), and Bank of America Corp (2.72%). SNPV's sector allocation is heavily weighted towards Technology (23.0%), Healthcare (18.9%), and Financial Services (17.4%). This sector focus distinguishes it from broader S&P 500 ETFs. The fund's methodology offers a strategic tilt towards value, potentially appealing to investors seeking a specific factor exposure within the large-cap U.S. equity market. Past performance does not guarantee future results.

Risk Metrics

SNPV, while diversified across 250 holdings, exhibits some concentration risk due to its top holdings. Palantir Technologies Inc Ordinary Shares - Class A, AbbVie Inc, and Bank of America Corp together constitute a significant portion of the fund's assets. The ETF's sector allocation also introduces risk, with a substantial weighting in Technology, Healthcare, and Financial Services. A downturn in these sectors could disproportionately impact SNPV's performance. With a beta of 0.93, SNPV is expected to exhibit slightly less volatility than the overall market. However, the fund's value-oriented strategy may lead to periods of underperformance relative to broader market indices, particularly during growth-driven market cycles. The expense ratio of 0.15% introduces a minor drag on returns, which should be considered in the overall risk assessment. Past performance does not guarantee future results.

Expense Ratio

0.15%

What does SNPV hold?

HoldingWeight
Palantir Technologies Inc Ordinary Shares - Class A (PLTR)3.03%
AbbVie Inc (ABBV)2.98%
Bank of America Corp (BAC)2.72%
Advanced Micro Devices Inc (AMD)2.56%
Oracle Corp (ORCL)2.43%
GE Aerospace (GE)2.41%
Cisco Systems Inc (CSCO)2.24%
UnitedHealth Group Inc (UNH)2.20%
Wells Fargo & Co (WFC)2.18%
Chevron Corp (CVX)2.12%

How Is the Fund Allocated?

SectorWeight
Technology23.0%
Healthcare18.9%
Financial Services17.4%
Industrials13.9%
Consumer Defensive7.3%
Consumer Cyclical5.8%
Communication Services5.6%
Energy3.0%
Utilities2.6%
Basic Materials1.5%
Real Estate1.1%
CountryWeight
United States80.6%
Other14.2%
Ireland2.9%
Switzerland1.1%
United Kingdom1.1%

Dividend Yield

1.95%

Risk Metrics

  • Beta: 0.93

Questions & Answers

What is SNPV and what does it track?

SNPV is the Xtrackers S&P 500 Value Scored & Screened ETF. It aims to replicate, before fees and expenses, the performance of the S&P 500 Value Scored & Screened Index.

This index screens and scores companies within the S&P 500 based on value characteristics, seeking to identify potentially undervalued stocks.

What is the expense ratio for SNPV?

The expense ratio for SNPV is 0.15%. This means that for every $10,000 invested in the fund, $15 is used to cover annual operating expenses.

While there isn't a definitive category average for value-focused ETFs that precisely matches SNPV's strategy, the expense ratio is relatively competitive compared to other actively managed or factor-based ETFs.

What are the top holdings in SNPV?

As of March 15, 2026, the top holdings in SNPV include Palantir Technologies Inc Ordinary Shares - Class A, with a weight of 3.03%, AbbVie Inc at 2.98%, and Bank of America Corp at 2.72%.

Other significant holdings include Advanced Micro Devices Inc (2.56%) and Oracle Corp (2.43%).

Is SNPV a good long-term investment?

Whether SNPV is a suitable long-term investment depends on an individual's investment goals, risk tolerance, and time horizon. SNPV offers exposure to value stocks within the S&P 500, which may outperform during certain market cycles.

The fund's expense ratio of 0.15% is relatively low, which can benefit long-term returns.

How does SNPV compare to similar ETFs?

SNPV differentiates itself through its unique scoring and screening methodology for identifying value stocks within the S&P 500.

While other value ETFs may focus on different indices or employ alternative weighting schemes, SNPV offers a specific approach to capturing the value factor. With an expense ratio of 0.15%, SNPV is competitively priced.

Does SNPV pay dividends?

Yes, SNPV does pay dividends. As of March 15, 2026, the fund has a dividend yield of 1.95%. This means that investors can expect to receive approximately 1.95% of their investment in annual dividend payments, although this can fluctuate.